ORPHA:641496
Childhood-onset schizophrenia
Also known as: COS · VEOS · Very early-onset schizophrenia
Publications
1,278
83.6th percentile
Trials
2
Interventional, condition-specific
Researchers
1,080
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare neurologic disease with psychiatric involvement characterized by prominent pre-psychotic developmental disabilities (cognitive, language, motor), socio-communicative disturbances, auditory hallucinations (visual and tactile hallucinations are rarer) preceding psychotic symptoms, presenting before 13 years of age. Co-occurrence of neurodevelopmental disorders (e.g. autism spectrum disorders, attention deficit hyperactivity disorder) is frequent. Disease course is more severe than adult-onset form of the disease, with major neurodevelopmental impact.
How rare: 1-5 / 10 000 — about one to five people per ten thousand (still uncommon, but less ultra-rare).
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0957430
- UMLS:C0036346
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
1,278 matched papers (521 in last 10 years) Source
- Phenotype characterisedNot found
No HPO disease–phenotype associations via Monarch for these Mondo IDs
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
2 matched on ClinicalTrials.gov
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
None returned for this Mondo ID. That often means “not linked under this ID,” not “no clinical features.”
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
2 associated chemicals. Therapeutic evidence is listed first when present — not a treatment recommendation.
- acetophenazine · therapeutic
- Clozapine · therapeutic
Literature
Is anyone studying this?
1,278
1,278 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
1,278 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
521 in the last 10 years · medium confidence · 83.6th percentile (publications denominator)
Phrase hits: 1,278 · MeSH hits: 0
Who's working on it?
1,080
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Rapoport JL10 papers · 2025
Child Psychiatry Branch, National Institute of Mental Health, NIH, Maryland.
Papers in Europe PMC - 02Vicari S7 papers · 2026
Child and Adolescence Neuropsychiatry Unit, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
Papers in Europe PMC - 03Driver DI6 papers · 2025
National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States of America.
Papers in Europe PMC - 04Markovic A6 papers · 2026
University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Switzerland; Graduate School for Health Sciences, University of Bern, Switzerland.
Papers in Europe PMC - 05Tarokh L6 papers · 2025
Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern, Bolligenstrasse 111, Haus A, 3000, Bern, Switzerland.
Papers in Europe PMC - 06Askenazy F5 papers · 2025
Department of Child and Adolescent Psychiatry, Children's Hospitals of Nice CHU-Lenval, 06200 Nice, France.
Papers in Europe PMC - 07Buckley A5 papers · 2025
National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States of America.
Papers in Europe PMC - 08Fernandez A5 papers · 2025
Department of Child and Adolescent Psychiatry, Children's Hospitals of Nice CHU-Lenval, 06200 Nice, France.
Papers in Europe PMC - 09Gochman P5 papers · 2018
Child Psychiatry Branch, National Institute of Mental Health, NIH, Maryland.
Papers in Europe PMC - 10Pontillo M5 papers · 2025
Child and Adolescence Neuropsychiatry Unit, Bambino Gesù Children's Hospital IRCCS, Rome, Italy. maria.pontillo@opbg.net.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
2
interventional trials for this specific condition
2 interventional trials matched this specific condition name; none in our sample are currently recruiting. 3,026 trials are registered for schizophrenia, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026
2 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 84.5th percentile).
medium confidence · 84.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
2 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Broader category: schizophrenia
3,026
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT06961968·RECRUITING·Randomized Withdrawal Study in Patients With Schizophrenia
Not reviewed·Conditions: Schizophrenia·Matched via name phrase
- NCT06923891·NOT YET RECRUITING·An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients
Not reviewed·Conditions: Schizophrenia·Matched via name phrase
- NCT04033679·RECRUITING·The Effects of Non-invasive Brain Stimulation on Treatment Adherence in Schizophrenia
Not reviewed·Conditions: Schizophrenia;Schizoaffective·Matched via name phrase
- NCT06613334·RECRUITING·Voice-Based Biomarkers: a Novel Approach to Monitoring and Predicting Schizophrenia Relapses
Not reviewed·Conditions: Schizophrenia·Matched via name phrase
- NCT04580134·RECRUITING·CLOZAPINE Response in Biotype-1
Not reviewed·Conditions: Schizophrenia · Schizoaffective Disorder · Bipolar 1 Disorder·Matched via name phrase
- NCT06894212·RECRUITING·A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
Not reviewed·Conditions: Schizophrenia·Matched via name phrase
- NCT05343598·RECRUITING·Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia
Not reviewed·Conditions: Schizophrenia · Schizo Affective Disorder·Matched via name phrase
- NCT07173192·ENROLLING BY INVITATION·The Effect of an Individual Empowerment Program Provided to Relatives of Schizophrenia Patients
Not reviewed·Conditions: Schizophrenia·Matched via name phrase
- NCT07459647·RECRUITING·A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Not reviewed·Conditions: Schizophrenia·Matched via name phrase
- NCT06944847·RECRUITING·Vaping and Smoking Project in People With Schizophrenia
Not reviewed·Conditions: Acute Abstinence From Cigarettes vs E-cigarettes (ENDS)·Matched via name phrase
- NCT07696000·RECRUITING·The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receiving Antipsychotic Therapy
Not reviewed·Conditions: Schizophrenia / Schizoaffective Disorder·Matched via name phrase
- NCT06880796·ENROLLING BY INVITATION·Mindfulness-Based Therapy for Serious Mental Illness
Not reviewed·Conditions: Serious Mental Illness · Schizophrenia · Major Depressive Disorder · Bipolar Disorder·Matched via name phrase
- NCT07557368·RECRUITING·Effects of Gamified Rehabilitation on Cognitive and Psychosocial Outcomes in Inpatients With Schizophrenia
Not reviewed·Conditions: Schizophrenia·Matched via name phrase
- NCT06045897·RECRUITING·EEG Microstates Across At-Risk Mental States
Not reviewed·Conditions: Psychotic Disorders · Autism Spectrum Disorder · Major Depressive Disorder · Schizophrenia·Matched via name phrase
- NCT05329363·RECRUITING·Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Disorders in Inpatients
Not reviewed·Conditions: Schizophrenia·Matched via name phrase
Observational and natural-history studies
1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
None of the matched observational studies is currently listed as recruiting.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Childhood-onset schizophrenia — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Childhood-onset schizophrenia" OR "Very early-onset schizophrenia"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Childhood-onset schizophrenia" OR "Very early-onset schizophrenia"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 2 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"schizophrenia"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: COS; VEOS
Confidence reasoning
- Preferred label is multi-word and distinctive
- 2 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T19:35:34.993Z
